2018
DOI: 10.12688/f1000research.13756.1
|View full text |Cite
|
Sign up to set email alerts
|

Extended pharmacological miosis is superfluous after glaucoma angle surgery: A retrospective study

Abstract: Background: Pilocarpine is commonly used after angle surgery for glaucoma despite a host of side effects and risks. We hypothesized that a pharmacological miosis during the first two months does not improve short- and long-term results of trabectome-mediated ab interno trabeculectomy. Methods: In this retrospective comparative 1-year case series, we compared 187 trabectome surgery eyes with (P+) or without (P-) 1% pilocarpine for two months. Primary outcome measures were the surgical success defined as intraoc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
3
2
1

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 35 publications
0
5
0
Order By: Relevance
“…To our knowledge, there are no published reports comparing postoperative steroids following goniotomy procedures. A study evaluating postoperative use of pilocarpine following standalone Trabectome surgery (NeoMedix, Tustin, California, United States of America) found no significant difference in IOP at any postoperative visit with or without pilocarpine, 8 suggesting that pilocarpine might not be superior in IOP-lowering after angle surgery. Our study supports the Trabectome study in that we found early postoperative pilocarpine use did not lead to fewer IOP-lowering drops long-term, although IOP was significantly lowered.…”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, there are no published reports comparing postoperative steroids following goniotomy procedures. A study evaluating postoperative use of pilocarpine following standalone Trabectome surgery (NeoMedix, Tustin, California, United States of America) found no significant difference in IOP at any postoperative visit with or without pilocarpine, 8 suggesting that pilocarpine might not be superior in IOP-lowering after angle surgery. Our study supports the Trabectome study in that we found early postoperative pilocarpine use did not lead to fewer IOP-lowering drops long-term, although IOP was significantly lowered.…”
Section: Discussionmentioning
confidence: 99%
“…For most surgeons, this includes intracameral and/or topical antibiotic therapy, a topical steroid taper, and possibly a topical nonsteroidal anti-inflammatory eye drop. There is no clear evidence that procedures to excise, ablate, open, or stent the trabecular meshwork do better with postoperative miotics [61], and it is not our practice to use them. Following ECP, we often lengthen the duration of the steroid taper to 2 or more months, tailored to the individual's anterior chamber inflammation.…”
Section: Postoperative Managementmentioning
confidence: 99%
“…In AIT, pilocarpine was used four times a day for one month followed by three times a day for a second month, a practice only recently found to be unnecessary. 20 Glaucoma medications were stopped at the day of surgery and restarted postoperatively as needed.…”
Section: Surgical Techniquementioning
confidence: 99%